Junhong Wang

5.6k total citations · 3 hit papers
161 papers, 4.1k citations indexed

About

Junhong Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Junhong Wang has authored 161 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 28 papers in Cardiology and Cardiovascular Medicine and 22 papers in Epidemiology. Recurrent topics in Junhong Wang's work include COVID-19 Clinical Research Studies (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Junhong Wang is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Cardiac Fibrosis and Remodeling (7 papers). Junhong Wang collaborates with scholars based in China, United States and Belarus. Junhong Wang's co-authors include Yan Guo, Xiaohan Xu, Ming Chu, Yixing Du, Nikolaos G. Frangogiannis, Michele Cavalera, Xiwen Lou, Jingxia Zhao, Zhibin Zhang and Hao Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Junhong Wang

154 papers receiving 4.0k citations

Hit Papers

FDA-approved disulfiram inhib... 2009 2026 2014 2020 2020 2009 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhong Wang China 30 1.4k 620 501 435 359 161 4.1k
Pallav Sengupta Malaysia 36 1.3k 1.0× 198 0.3× 521 1.0× 641 1.5× 386 1.1× 188 7.0k
Martin Hill Czechia 48 1.6k 1.2× 400 0.6× 395 0.8× 382 0.9× 556 1.5× 437 9.4k
Yi Qu China 44 1.8k 1.3× 278 0.4× 333 0.7× 215 0.5× 708 2.0× 331 6.3k
Ming Li China 45 2.3k 1.6× 688 1.1× 855 1.7× 200 0.5× 710 2.0× 330 7.8k
Dezhi Mu China 48 2.6k 1.9× 350 0.6× 645 1.3× 204 0.5× 1.1k 3.1× 350 8.2k
Yuanyuan Xu China 41 2.1k 1.5× 496 0.8× 307 0.6× 1.5k 3.4× 456 1.3× 226 5.7k
Cong Huang China 36 1.2k 0.9× 257 0.4× 145 0.3× 193 0.4× 219 0.6× 160 4.5k
Lihong Wang China 43 3.7k 2.7× 217 0.3× 480 1.0× 166 0.4× 280 0.8× 248 6.3k
Alison C. Holloway Canada 44 1.0k 0.8× 232 0.4× 482 1.0× 881 2.0× 479 1.3× 172 5.8k
Hui Wang China 44 3.1k 2.2× 191 0.3× 757 1.5× 246 0.6× 588 1.6× 522 9.2k

Countries citing papers authored by Junhong Wang

Since Specialization
Citations

This map shows the geographic impact of Junhong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhong Wang more than expected).

Fields of papers citing papers by Junhong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhong Wang. The network helps show where Junhong Wang may publish in the future.

Co-authorship network of co-authors of Junhong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junhong Wang. A scholar is included among the top collaborators of Junhong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhong Wang. Junhong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Xiaoyu, Yu Zou, Na Su, et al.. (2025). Novel 2D/3D vascular biomarkers reveal association between fundus changes and coronary heart disease. Microvascular Research. 159. 104793–104793.
2.
Wang, Junhong, et al.. (2025). Reviving hope: Phage therapy application for antimicrobial resistance in farm animal production over the past decade. Animal Feed Science and Technology. 324. 116333–116333. 3 indexed citations
3.
Cao, Lu, et al.. (2025). Increased Plasma Pyruvate Kinase M2 (PK‐M2) in Heart Failure: A Novel Biomarker Related to Cardiac Function and its Clinical Implications. Journal of the American Heart Association. 14(2). e036170–e036170. 1 indexed citations
4.
Doyle, David, et al.. (2024). Noise Removal in Single-Lead Capacitive ECG With Adaptive Filtering and Singular Value Decomposition. IEEE Access. 12. 152777–152785. 3 indexed citations
5.
Zhou, Zixuan, et al.. (2024). Establishment of a microspheres-based homogeneous fluorescence immunoassay for the rapid detection of cardiac troponin I. Analytical Methods. 16(26). 4402–4408. 2 indexed citations
6.
Wang, Junhong, et al.. (2023). Safety and Efficacy of Carbon Nanoparticle-Labeled Lymph Node Dissection in Radical Resection of Gastric Cancer: A Systematic Review and Meta-Analysis. Technology in Cancer Research & Treatment. 22. 2223895982–2223895982. 3 indexed citations
7.
Wu, Jing, Junhong Wang, Jae‐Hoon Choi, et al.. (2023). Bioactive Compounds from the Mushroom-Forming Fungus Chlorophyllum molybdites. Antibiotics. 12(3). 596–596. 5 indexed citations
8.
Pan, Xu, Junhong Wang, Ye Chen, et al.. (2023). Fe-Ni alloy modified Zr-based MOF derivatives as bioelectrocatalyst for regulating multipath EET efficiency and biofilm electrogenic activity. Applied Surface Science. 640. 158436–158436. 8 indexed citations
9.
Zhang, Yi, Shan Ma, Zheng‐Da Pang, et al.. (2023). AGEs-RAGE-KCa3.1 pathway mediates palmitic acid-induced migration of PBMCs from patients with type 2 diabetes. Heliyon. 9(4). e14823–e14823. 3 indexed citations
10.
Chen, Yuru, Yanyan Wang, Yu Zhai, et al.. (2023). Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway. Frontiers in Pharmacology. 14. 1081363–1081363. 5 indexed citations
11.
Shao, Rui, Renping Zhao, Mingyu Ding, et al.. (2023). Bioactive Constituents of Verbena officinalis Alleviate Inflammation and Enhance Killing Efficiency of Natural Killer Cells. International Journal of Molecular Sciences. 24(8). 7144–7144. 10 indexed citations
12.
13.
Hu, Guixian, Xue Li, Yan Liu, et al.. (2023). Comparative Analysis of the Nutritional Quality of Zizania latifolia Cultivars Harvested in Different Growing Seasons. Foods. 13(1). 30–30. 3 indexed citations
14.
Zhu, Zuoyi, Yu Zhang, Wei Wang, et al.. (2020). Structural characterisation and antioxidant activity of melanoidins from high‐temperature fermented apple. International Journal of Food Science & Technology. 56(5). 2471–2480. 10 indexed citations
16.
Wang, Junhong, et al.. (2018). Pitavastatin attenuates AGEs-induced mitophagy via inhibition of ROS generation in the mitochondria of cardiomyocytes. Journal of Biomedical Research. 32(4). 281–281. 10 indexed citations
17.
Wang, Junhong, Shan Gao, Wenwen Xin, et al.. (2015). A novel recombinant vaccine protecting mice against abrin intoxication. Human Vaccines & Immunotherapeutics. 11(6). 1361–1367. 5 indexed citations
18.
Zhang, Tao, Lin Kang, Shan Gao, et al.. (2014). Truncated abrin A chain expressed inEscherichia coli: A promising vaccine candidate. Human Vaccines & Immunotherapeutics. 10(9). 2648–2655. 9 indexed citations
19.
Xin, Wenwen, Lin Kang, Shan Gao, et al.. (2014). Preparation of egg yolk antibodies against BoNT/B and their passive protection in mouse models. Human Vaccines & Immunotherapeutics. 10(8). 2321–2327. 6 indexed citations
20.
Wang, Junhong, Guangming Qin, Songzhao Zhang, & Yaping Jin. (2005). Efficient measurement of platelet-monocyte aggregates in whole blood by flow cytometry. Zhonghua jianyan yixue zazhi. 28(12). 1288–1291. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026